WallStreetZenWallStreetZen

NASDAQ: AURA
Aura Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AURA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$76.4M
Current Profit Margin
0%

AURA Return on Equity

Current Company
-42.2%
Current Industry
-63.5%
Current Market
188%
AURA's Return on Equity (-42.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AURA announces earnings.

AURA Return on Assets

Current Company
-36.7%
Current Industry
2.9%
AURA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AURA Return on Capital Employed

Current Company
-31.42%
Current Industry
19.5%
AURA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AURA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AURA$0.00-$73.14M-$76.41MN/AN/A
RANI$0.00-$27.02M-$33.97M-100.00%N/A
MNMD$0.00-$92.57M-$95.73MN/AN/A
CBUS$1.82M-$244.57M-$267.63M+50.41%N/A
NKTX$0.00-$109.41M-$117.50M-100.00%N/A
View Top Biotech Stocks

AURA earnings dates

Next earnings date
May 6, 2024

Aura Biosciences Earnings & Revenue FAQ

What were AURA's earnings last quarter?

On Invalid Date, Aura Biosciences (NASDAQ: AURA) reported Q4 2023 earnings per share (EPS) of -$0.50, up 3.85% year over year. Total Aura Biosciences earnings for the quarter were -$22.13 million. In the same quarter last year, Aura Biosciences's earnings per share (EPS) was -$0.52.

If you're new to stock investing, here's how to buy Aura Biosciences stock.

What was AURA's earnings growth in the past year?

As of Q2 2024, Aura Biosciences's earnings has grown year over year. Aura Biosciences's earnings in the past year totalled -$76.41 million.

What is AURA's earnings date?

Aura Biosciences's earnings date is Invalid Date. Add AURA to your watchlist to be reminded of AURA's next earnings announcement.

What was AURA's revenue last quarter?

On Invalid Date, Aura Biosciences (NASDAQ: AURA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aura Biosciences's revenue was $0.00.

What was AURA's revenue growth in the past year?

As of Q2 2024, Aura Biosciences's revenue has grown null year over year. Aura Biosciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.